Revvity Total Liabilities and Share Holders Equity 2010-2024 | RVTY
- Revvity total liabilities and share holders equity for the quarter ending September 30, 2024 was $12.770B, a 4.86% decline year-over-year.
- Revvity total liabilities and share holders equity for 2023 was $13.565B, a 4% decline from 2022.
- Revvity total liabilities and share holders equity for 2022 was $14.13B, a 5.8% decline from 2021.
- Revvity total liabilities and share holders equity for 2021 was $15.001B, a 88.44% increase from 2020.
Revvity Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
---|---|
2023 | $13,565 |
2022 | $14,130 |
2021 | $15,001 |
2020 | $7,960 |
2019 | $6,539 |
2018 | $5,976 |
2017 | $6,091 |
2016 | $4,277 |
2015 | $4,166 |
2014 | $4,128 |
2013 | $3,947 |
2012 | $3,902 |
2011 | $3,856 |
2010 | $3,209 |
2009 | $3,059 |
Revvity Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
---|---|
2024-09-30 | $12,770 |
2024-06-30 | $13,425 |
2024-03-31 | $13,433 |
2023-12-31 | $13,565 |
2023-09-30 | $13,422 |
2023-06-30 | $14,219 |
2023-03-31 | $14,638 |
2022-12-31 | $14,130 |
2022-09-30 | $13,824 |
2022-06-30 | $14,190 |
2022-03-31 | $14,848 |
2021-12-31 | $15,001 |
2021-09-30 | $14,900 |
2021-06-30 | $8,739 |
2021-03-31 | $8,763 |
2020-12-31 | $7,960 |
2020-09-30 | $6,866 |
2020-06-30 | $6,637 |
2020-03-31 | $6,384 |
2019-12-31 | $6,539 |
2019-09-30 | $6,489 |
2019-06-30 | $6,399 |
2019-03-31 | $6,086 |
2018-12-31 | $5,976 |
2018-09-30 | $5,862 |
2018-06-30 | $5,958 |
2018-03-31 | $6,126 |
2017-12-31 | $6,091 |
2017-09-30 | $4,739 |
2017-06-30 | $4,605 |
2017-03-31 | $4,341 |
2016-12-31 | $4,277 |
2016-09-30 | $4,305 |
2016-06-30 | $4,194 |
2016-03-31 | $4,211 |
2015-12-31 | $4,166 |
2015-09-30 | $4,032 |
2015-06-30 | $4,083 |
2015-03-31 | $4,028 |
2014-12-31 | $4,128 |
2014-09-30 | $3,886 |
2014-06-30 | $3,937 |
2014-03-31 | $3,971 |
2013-12-31 | $3,947 |
2013-09-30 | $3,852 |
2013-06-30 | $3,811 |
2013-03-31 | $3,808 |
2012-12-31 | $3,902 |
2012-09-30 | $3,890 |
2012-06-30 | $3,801 |
2012-03-31 | $3,864 |
2011-12-31 | $3,856 |
2011-09-30 | $3,402 |
2011-06-30 | $3,596 |
2011-03-31 | $3,306 |
2010-12-31 | $3,209 |
2010-09-30 | $3,248 |
2010-06-30 | $3,146 |
2010-03-31 | $3,027 |
2009-12-31 | $3,059 |
2009-09-30 | $3,059 |
2009-06-30 | $2,946 |
2009-03-31 | $2,858 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $14.905B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $98.015B | 12.16 |
Cencora (COR) | United States | $48.948B | 18.05 |
DiDi Global (DIDIY) | China | $23.622B | 0.00 |
ICON (ICLR) | Ireland | $17.731B | 15.79 |
Natera (NTRA) | United States | $16.587B | 0.00 |
Viatris (VTRS) | United States | $15.469B | 4.76 |
Avantor (AVTR) | United States | $15.375B | 23.05 |
BioMerieux (BMXMF) | France | $13.087B | 0.00 |
CochLear (CHEOY) | Australia | $12.590B | 0.00 |
Solventum (SOLV) | United States | $12.509B | 0.00 |
Medpace Holdings (MEDP) | United States | $11.276B | 31.77 |
Charles River Laboratories (CRL) | United States | $11.014B | 21.28 |
Doximity (DOCS) | United States | $10.815B | 64.01 |
HealthEquity (HQY) | United States | $8.629B | 46.83 |
Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $7.043B | 32.79 |
Life Times (LTH) | United States | $5.170B | 34.22 |
Sotera Health (SHC) | United States | $4.557B | 24.38 |
Organon (OGN) | United States | $4.131B | 4.17 |
Surgery Partners (SGRY) | United States | $3.859B | 42.76 |
BrightSpring Health Services (BTSG) | United States | $3.408B | 72.48 |
PACS (PACS) | United States | $3.251B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.620B | 0.00 |
Concentras Parent (CON) | United States | $2.500B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.337B | 0.00 |
Premier (PINC) | United States | $2.292B | 11.44 |
GeneDx Holdings (WGS) | United States | $2.137B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
Teladoc Health (TDOC) | United States | $1.589B | 0.00 |
Progyny (PGNY) | United States | $1.499B | 26.37 |
Pediatrix Medical (MD) | United States | $1.353B | 13.24 |
Establishment Labs Holdings (ESTA) | $1.292B | 0.00 | |
CareDx (CDNA) | United States | $1.268B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.104B | 7.49 |
Embecta (EMBC) | United States | $0.897B | 5.98 |
InnovAge Holding (INNV) | United States | $0.813B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.757B | 0.00 |
SBC Medicals (SBC) | United States | $0.706B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
DocGo (DCGO) | United States | $0.409B | 15.38 |
Enhabit (EHAB) | United States | $0.397B | 34.30 |
COMPASS Pathways (CMPS) | United Kingdom | $0.373B | 0.00 |
LifeMD (LFMD) | United States | $0.252B | 0.00 |
Sera Prognostics (SERA) | United States | $0.225B | 0.00 |
ModivCare (MODV) | United States | $0.221B | 12.05 |
Beauty Health (SKIN) | United States | $0.202B | 0.00 |
Biodesix (BDSX) | United States | $0.199B | 0.00 |
Nutex Health (NUTX) | United States | $0.160B | 0.00 |
MultiPlan (MPLN) | United States | $0.137B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
So-Young (SY) | China | $0.089B | 21.63 |
Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.055B | 0.00 |
OncoCyte (OCX) | United States | $0.048B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.11 |
Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
Oncology Institute (TOI) | United States | $0.020B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
KindlyMD (KDLY) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |